UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5770) 5770
Newsletter (200) 200
Newspaper Article (43) 43
Book Chapter (42) 42
Magazine Article (28) 28
Dissertation (12) 12
Publication (6) 6
Conference Proceeding (5) 5
Book Review (1) 1
Government Document (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4336) 4336
science & technology (3866) 3866
life sciences & biomedicine (3676) 3676
hiv infections - drug therapy (2658) 2658
male (2592) 2592
ritonavir (2586) 2586
female (2291) 2291
infectious diseases (2099) 2099
adult (2092) 2092
ritonavir - therapeutic use (2054) 2054
biological and medical sciences (1626) 1626
medical sciences (1613) 1613
middle aged (1595) 1595
ritonavir - administration & dosage (1476) 1476
antiviral agents (1460) 1460
pharmacology & pharmacy (1447) 1447
drug therapy, combination (1432) 1432
lopinavir (1388) 1388
pharmacology. drug treatments (1286) 1286
hiv protease inhibitors - therapeutic use (1280) 1280
hiv (1197) 1197
ritonavir - adverse effects (1060) 1060
aids/hiv (1048) 1048
antibiotics. antiinfectious agents. antiparasitic agents (966) 966
viral diseases (956) 956
anti-hiv agents - therapeutic use (955) 955
immunology (948) 948
virology (926) 926
human viral diseases (837) 837
treatment outcome (831) 831
protease inhibitors (816) 816
hiv protease inhibitors - administration & dosage (811) 811
drug therapy (790) 790
hiv infections - virology (786) 786
human immunodeficiency virus--hiv (783) 783
ritonavir - pharmacology (780) 780
microbiology (772) 772
viral load (768) 768
drug interactions (757) 757
viral diseases of the lymphoid tissue and the blood. aids (752) 752
hiv protease inhibitors - adverse effects (736) 736
ritonavir - pharmacokinetics (734) 734
antiretroviral drugs (652) 652
anti-hiv agents - administration & dosage (649) 649
hiv-1 - drug effects (632) 632
cd4 lymphocyte count (560) 560
hiv infection (558) 558
hiv protease inhibitors - pharmacology (558) 558
drug combinations (555) 555
hiv protease inhibitors - pharmacokinetics (542) 542
aged (513) 513
antiretroviral therapy (486) 486
anti-hiv agents - adverse effects (471) 471
research (450) 450
darunavir (445) 445
adolescent (430) 430
health aspects (430) 430
hiv-1 (428) 428
pharmacokinetics (428) 428
drug administration schedule (411) 411
antiretroviral therapy, highly active (406) 406
pyrimidinones - therapeutic use (406) 406
patients (402) 402
immunopathology (400) 400
immunodeficiencies. immunoglobulinopathies (399) 399
immunodeficiencies (398) 398
analysis (391) 391
rna, viral - blood (390) 390
young adult (388) 388
animals (387) 387
highly active antiretroviral therapy (384) 384
atazanavir sulfate (382) 382
sulfonamides - therapeutic use (377) 377
lopinavir - therapeutic use (369) 369
antiviral agents - therapeutic use (361) 361
proteases (360) 360
virus diseases (360) 360
dosage and administration (354) 354
reverse transcriptase inhibitors - therapeutic use (353) 353
hiv-1 - genetics (349) 349
aids (346) 346
clinical trials (346) 346
human immunodeficiency virus (345) 345
abridged index medicus (343) 343
anti-hiv agents - pharmacokinetics (338) 338
tenofovir (324) 324
pharmacology (323) 323
hiv infections - complications (322) 322
hiv infections - immunology (318) 318
care and treatment (314) 314
hiv infections - blood (313) 313
covid-19 (308) 308
sulfonamides - administration & dosage (308) 308
prospective studies (307) 307
genotype (299) 299
pyrimidinones - administration & dosage (296) 296
ritonavir - blood (296) 296
retrospective studies (294) 294
pyridines - therapeutic use (285) 285
drugs (279) 279
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5867) 5867
Spanish (120) 120
French (49) 49
German (45) 45
Portuguese (32) 32
Japanese (23) 23
Chinese (20) 20
Russian (16) 16
Czech (5) 5
Italian (5) 5
Hungarian (4) 4
Korean (4) 4
Dutch (3) 3
Danish (2) 2
Hebrew (1) 1
Persian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases, ISSN 1058-4838, 2/2012, Volume 54, Issue 3, pp. 414 - 423
Statistical median | HIV/AIDS | HIV | Memory interference | Drug interactions | Medications | Methadone | Pharmacokinetics | Dosage | Data ranges | Opioid analgesics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Biological and medical sciences | Infectious diseases | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | History, 17th Century | Narcotic Antagonists - administration & dosage | Darunavir | Area Under Curve | Buprenorphine - blood | Protease Inhibitors - pharmacokinetics | Humans | Half-Life | Buprenorphine - pharmacokinetics | Male | Carbamates - administration & dosage | Carbamates - pharmacokinetics | Anti-HIV Agents - administration & dosage | Sulfonamides - blood | Drug Interactions | Buprenorphine - analogs & derivatives | Protease Inhibitors - administration & dosage | Female | Opiate Substitution Treatment | Anti-HIV Agents - blood | Narcotic Antagonists - pharmacokinetics | Organophosphates - administration & dosage | Organophosphates - pharmacokinetics | Ritonavir - administration & dosage | Organophosphates - blood | Ritonavir - blood | History, 16th Century | Carbamates - blood | Sulfonamides - pharmacokinetics | Buprenorphine - administration & dosage | Ritonavir - pharmacokinetics | Naloxone - pharmacology | Anti-HIV Agents - pharmacokinetics | Protease Inhibitors - blood | Sulfonamides - administration & dosage | Usage | Fosamprenavir | Dosage and administration | Buprenorphine | Protease inhibitors | Substance abuse treatment | Metabolites | Human immunodeficiency virus--HIV | Pain management | Index Medicus | AIDS
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2020, Volume 382, Issue 19, pp. 1787 - 1799
Journal Article
by Arabi, Yaseen M and Alothman, Adel and Balkhy, Hanan H and Al-Dawood, Abdulaziz and AlJohani, Sameera and Al Harbi, Shmeylan and Kojan, Suleiman and Al Jeraisy, Majed and Deeb, Ahmad M and Assiri, Abdullah M and Al-Hameed, Fahad and AlSaedi, Asim and Mandourah, Yasser and Almekhlafi, Ghaleb A and Sherbeeni, Nisreen Murad and Elzein, Fatehi Elnour and Memon, Javed and Taha, Yusri and Almotairi, Abdullah and Maghrabi, Khalid A and Qushmaq, Ismael and Al Bshabshe, Ali and Kharaba, Ayman and Shalhoub, Sarah and Jose, Jesna and Fowler, Robert A and Hayden, Frederick G and Hussein, Mohamed A and Martin, Greg S and Schoenfeld, David A and Walmsley, Sharon L and Carson, Shannon and Harbi, Shmeylan Al and Jeraisy, Majed Al and Muhaidib, Mohammed Al and Musharaf, Sadat and Anizi, Hala Al and Dael, Reggie and AlMazroa, Mohammad and Asiri, Ayed and Memish, Ziad A and Ghazal, Sameeh S and Alfaraj, Sarah H and Harthy, Abdulrahman Al and Sulaiman, Mohammed Al and Mady, Ahmed and Ahmad, Abdulrauf and Ghaleb A Almekhlafi, A Almekhlafi and Muhammed, Reema and Samirrai, Shatha Al and Awad, Shatha and Cabal, Rylen Cabio and Onazi, Bander Al and Aljuhani, Maha and Vince, Melven and Enani, Mushira Al and Alqurashi, Alaa and Alenezi, Fatimah and Alkhani, Nada and Thaqafi, Abdulhakeem and Oraabi, Ohoud Al and Rifai, Jalal and Elsamadisi, Pansy and Medhat, S.Hendy and Basher, Sara AbuBaker and Abduldhaher, Muhammed and Bajhamoum, Wael and Alahsa, Sarah Shalhoub and Bashir, Shahinaz and Al-Dossary, Ibraheem and Al-Muhainy Dammam, Bader and Khobar, Shehab Suliman Al and Alshahrani, Mohammed S and Al Jabri, Ahmad and Farid, Magdy and Alaidarous, Alawi and Alseraihi, Wael and Shahada, Husam and Taif, Jinish Shimi and And the MIRACLE trial group
Trials, ISSN 1745-6215, 01/2018, Volume 19, Issue 1, pp. 81 - 81
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2020, Volume 323, Issue 15, pp. 1488 - 1494
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 12, pp. 2112 - 2118
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | Biological and medical sciences | General aspects | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9568, pp. 1169 - 1178
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Acta biomaterialia, ISSN 1742-7061, 07/2018, Volume 74, pp. 344 - 359
HIV/AIDS | Nanoparticle-in-microparticle delivery system | Oral pharmacokinetics | Darunavir/ritonavir | Antiretroviral therapy | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | HIV-1 | Darunavir - pharmacokinetics | Nanoparticles - chemistry | Administration, Oral | Rats | HIV Protease Inhibitors - chemistry | Male | Darunavir - chemistry | Rats, Sprague-Dawley | Ritonavir - chemistry | HIV Protease Inhibitors - pharmacology | Animals | Darunavir - pharmacology | Ritonavir - pharmacokinetics | HIV Infections - pathology | HIV Protease Inhibitors - pharmacokinetics | Nanoparticles - therapeutic use | HIV Infections - drug therapy | Ritonavir - pharmacology | Drug Delivery Systems - methods | HIV Infections - metabolism | Drugs | Highly active antiretroviral therapy | Drug delivery systems | Protease inhibitors | Proteases | Vehicles | Ritonavir | Alginic acid | Drug development | pH effects | Small intestine | Microparticles | Acquired immune deficiency syndrome--AIDS | Protease | Human immunodeficiency virus--HIV | Antiretroviral drugs | Stability | Chemical precipitation | Solubility | Proteinase inhibitors | Bioavailability | Weight | Sodium | Recrystallization | Chitosan | Physicochemical properties | Encapsulation | Viscosity | Calcium | Viruses | Drug delivery | Hydrophobicity | Coatings | Nanoparticles | Antiretroviral agents | Calcium alginate | Rodents | pH | Formulations | Antiviral agents | Stomach | Oral administration | Pharmacology | Gastrointestinal tract | Evaporation | Dissolution | Drug administration | Acids | Pharmacokinetics | Nanotechnology | Polymorphism | Pharmaceuticals | Index Medicus
Journal Article